Verition Fund Management »

Urogen Pharma shares owned by Verition Fund Management

Quarter-by-quarter ownership of Urogen Pharma (URGN) shares owned by Verition Fund Management from 13F filings

Historical chart of Verition Fund Management investment in Urogen Pharma

Tip: Access up to 7 years of quarterly data

All positions including Urogen Pharma held by Verition Fund Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Urogen Pharma by Verition Fund Management

Quarter filed Position value Share count Share price at filing
2023-09-30 $238k 17k 14.01

More positions owned by Verition Fund Management

Activision Blizzard
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Apple Put Option (AAPL)
Nisource Unit 12/01/2023
Biogen Idec Put Option (BIIB)
Xcel Energy (XEL)
Alphabet Cap Stk Cl A (GOOGL)
Consolidated Edison (ED)
Hartford Financial Services (HIG)
Renaissance Re Holdings Ltd Cmn (RNR)
Ishares Tr Msci Emg Mkt Etf Call Option (EEM)
Sempra Energy (SRE)
Chubb (CB)
Microsoft Corporation (MSFT)
Southern Company Put Option (SO)

View all positions for Verition Fund Management

Top funds holding Urogen Pharma

RA Capital Management
Dr. Jeffrey R. Jay, M.D.
Credit Suisse
Harel Insurance Investments & Financial Services
Migdal Insurance & Financial Holdings
Millennium Management
Opaleye Management
Superstring Capital Management
Laurion Capital Management
Wells Fargo & Company
Citadel Advisors
Vanguard Group
ARK Investment Management
AlphaCentric Advisors
Schonfeld Strategic Advisors

View all funds holding Urogen Pharma